Cleared Traditional

K850629 - INNOFLUOR THEOPHYLLINE

K850629 is an FDA 510(k) clearance for INNOFLUOR THEOPHYLLINE, manufactured by Innotron Diagnostics. The device is a Class 2 Chemistry device with product code LGS cleared through the Traditional 510(k) pathway after a 21-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1985
Decision
21d
Days
Class 2
Risk

K850629 is an FDA 510(k) clearance for the INNOFLUOR THEOPHYLLINE. Classified as Fluorescence Polarization Immunoassay, Theophylline (product code LGS), Class II - Special Controls.

Submitted by Innotron Diagnostics (Irvine, US). The FDA issued a Cleared decision on March 12, 1985 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3880 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K850629

510(k) Number K850629 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 1985
Decision Date March 12, 1985
Days to Decision 21 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 89d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LGS Device Classification - Class 2, Special Controls

Product Code LGS Fluorescence Polarization Immunoassay, Theophylline
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3880
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - LGS Fluorescence Polarization Immunoassay, Theophylline

All 12
Devices cleared under the same product code (LGS) and FDA review panel - the closest regulatory comparables to K850629.
FPR THEOPHYLLINE KIT
K894529 · Colony Laboratories, Inc. · Sep 1989
COBAS FP REAGENTS FOR THEOPHYLLINE & CALIBRATORS
K871484 · Roche Diagnostic Systems, Inc. · May 1987
MONITORX LASERX THEOPHYLLINE REAGENT SET
K870277 · American Monitor Corp. · Feb 1987
COBAS IMMUNOASSAY FOR THEOPHYLLINE & CAL
K843826 · Roche Diagnostic Systems, Inc. · Feb 1985